Proteomic analysis reveals a protective role for DJ-1 during 6-hydroxydopamine-induced cell death

Biochemical and Biophysical Research Communications

Volumn 422, Issue 1, 2012, Pages 8-14

  Kim, Su Jeong ^a   Park, Yun Jong ^a   Oh, Young J ^a  

^a Yonsei University   (South Korea)

Author keywords

6 Hydroxydopamine; DJ 1 PARK7; Parkinson's disease; Proteomics

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADENYLATE KINASE; ALPHA ENOLASE; CALPONIN; DIMETHYLARGININASE; DJ 1 PROTEIN; GALECTIN 1; GALECTIN 7; GLYCOGEN PHOSPHORYLASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; INORGANIC PYROPHOSPHATASE; OXIDOPAMINE; PEROXIREDOXIN 2; PEROXIREDOXIN 6; PHOSPHOGLYCERATE DEHYDROGENASE; PROTEIN DISULFIDE ISOMERASE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; STATHMIN; TRANSGELIN; UBIQUITIN THIOLESTERASE;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMMUNOBLOTTING; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; APOPTOSIS; CELL LINE; CYTOPROTECTION; DOPAMINERGIC NEURONS; GENE KNOCKDOWN TECHNIQUES; MICE; ONCOGENE PROTEINS; OXIDOPAMINE; PROTEOMICS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84861455505     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.04.063     Document Type: Article

References (34)

1. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
2. Hardy J., Lewis P., Revesz T., Lees A., Paisan-Ruiz C. The genetics of Parkinson's syndromes: a critical review. Curr. Opin. Genet. Dev. 2009, 19:254-265.
3. van Duijn C.M., Dekker M.C., Bonifati V., Galjaard R.J., Houwing-Duistermaat J.J., Snijders P.J., Testers L., Breedveld G.J., Horstink M., Sandkuijl L.A., van Swieten J.C., Oostra B.A., Heutink P. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am. J. Hum. Genet. 2001, 69:629-634.
4. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C., Squitieri F., Ibanez P., Joosse M., van Dongen J.W., Vanacore N., van Swieten J.C., Brice A., Meco G., van Duijn C.M., Oostra B.A., Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003, 299:256-259.
5. Kahle P.J., Waak J., Gasser T. DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders. Free Radic. Biol. Med. 2009, 47:1354-1361.
6. Canet-Aviles R.M., Wilson M.A., Miller D.W., Ahmad R., McLendon C., Bandyopadhyay S., Baptista M.J., Ringe D., Petsko G.A., Cookson M.R. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. USA 2004, 101:9103-9108.
7. Thomas K.J., McCoy M.K., Blackinton J., Beilina A., van der Brug M., Sandebring A., Miller D., Maric D., Cedazo-Minguez A., Cookson M.R. DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Hum. Mol. Genet. 2011, 20:40-50.
8. Krebiehl G., Ruckerbauer S., Burbulla L.F., Kieper N., Maurer B., Waak J., Wolburg H., Gizatullina Z., Gellerich F.N., Woitalla D., Riess O., Kahle P.J., Proikas-Cezanne T., Kruger R. Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1. Plos One 2010, 5.
9. Xu J., Zhong N., Wang H., Elias J.E., Kim C.Y., Woldman I., Pifl C., Gygi S.P., Geula C., Yankner B.A. The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Hum. Mol. Genet. 2005, 14:1231-1241.
10. Nishinaga H., Takahashi-Niki K., Taira T., Andreadis A., Iguchi-Ariga S.M., Ariga H. Expression profiles of genes in DJ-1-knockdown and L 166 P DJ-1 mutant cells. Neurosci. Lett. 2005, 390:54-59.
11. Zhou W., Freed C.R. DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J. Biol. Chem. 2005, 280:43150-43158.
12. Zhong N., Xu J. Synergistic activation of the human MnSOD promoter by DJ-1 and PGC-1alpha: regulation by SUMOylation and oxidation. Hum. Mol. Genet. 2008, 17:3357-3367.
13. Fan J., Ren H., Jia N., Fei E., Zhou T., Jiang P., Wu M., Wang G. DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J. Biol. Chem. 2008, 283:4022-4030.
14. Han B.S., Hong H.S., Choi W.S., Markelonis G.J., Oh T.H., Oh Y.J. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. J. Neurosci. 2003, 23:5069-5078.
15. Lee Y.M., Park S.H., Shin D.I., Hwang J.Y., Park B., Park Y.J., Lee T.H., Chae H.Z., Jin B.K., Oh T.H., Oh Y.J. Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease. J. Biol. Chem. 2008, 283:9986-9998.
16. Choi W.S., Yoon S.Y., Oh T.H., Choi E.J., O'Malley K.L., Oh Y.J. Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: Role of caspases, ROS, and JNK. J. Neurosci. Res. 1999, 57:86-94.
17. Taira T., Saito Y., Niki T., Iguchi-Ariga S.M.M., Takahashi K., Ariga H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 2004, 5:213-218.
18. Kuwabara I., Kuwabara Y., Yang R.Y., Schuler M., Green D.R., Zuraw B.L., Hsu D.K., Liu F.T. Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release. J. Biol. Chem. 2002, 277:3487-3497.
19. Choi H., Chang J.W., Jung Y.K. Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspase. Cell Death Differ. 2011, 18:405-414.
20. Kim S.Y., Chun E., Lee K.Y. Phospholipase A(2) of peroxiredoxin 6 has a critical role in tumor necrosis factor-induced apoptosis. Cell Death Differ. 2011, 18:1573-1583.
21. Da Silva-Azevedo L., Jahne S., Hoffmann C., Stalder D., Heller M., Pries A.R., Zakrzewicz A., Baum O. Up-regulation of the peroxiredoxin-6 related metabolism of reactive oxygen species in skeletal muscle of mice lacking neuronal nitric oxide synthase. J. Physiol. London 2009, 587:655-668.
22. Blum D., Wu Y., Nissou M.F., Arnaud S., Benabid A.L., Verna J.M. P53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells. Brain Res. 1997, 751:139-142.
23. Mandir A.S., Simbulan-Rosenthal C.M., Poitras M.F., Lumpkin J.R., Dawson V.L., Smulson M.E., Dawson T.M. A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism. J. Neurochem. 2002, 83:186-192.
24. Duan W., Zhu X., Ladenheim B., Yu Q.S., Guo Z., Oyler J., Cutler R.G., Cadet J.L., Greig N.H., Mattson M.P. P53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism. Ann. Neurol. 2002, 52:597-606.
25. Nair V.D. Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson's disease. Apoptosis 2006, 11:955-966.
26. Bretaud S., Allen C., Ingham P.W., Bandmann O. P53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. J. Neurochem. 2007, 100:1626-1635.
27. Hoh J., Jin S., Parrado T., Edington J., Levine A.J., Ott J. The p53MH algorithm and its application in detecting p53-responsive genes. Proc. Natl. Acad. Sci. USA 2002, 99:8467-8472.
28. Rhee S.G., Chae H.Z., Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 2005, 38:1543-1552.
29. Levine A.J., Oren M. The first 30 years of p53: growing ever more complex. Nat. Rev. Cancer 2009, 9:749-758.
30. Liu D., Xu Y. P53, oxidative stress, and aging. Antioxid. Redo. Signal. 2011, 15:1669-1678.
31. Morey M., Corominas M., Serras F. DIAP1 suppresses ROS-induced apoptosis caused by impairment of the selD/sps1 homolog in Drosophila. J. Cell Sci. 2003, 116:4597-4604.
32. Chung H.J., Yoon S.I., Shin S.H., Koh Y.A., Lee S.J., Lee Y.S., Bae S. P53-Mediated enhancement of radiosensitivity by selenophosphate synthetase 1 overexpression. J. Cell Physiol. 2006, 209:131-141.
33. Pfeiffer-Guglielmi B., Fleckenstein B., Jung G., Hamprecht B. Immunocytochemical localization of glycogen phosphorylase isozymes in rat nervous tissues by using isozyme-specific antibodies. J. Neurochem. 2003, 85:73-81.
34. Favre C., Aguilar P.S., Carrillo M.C. Oxidative stress and chronological aging in glycogen-phosphorylase-deleted yeast. Free Radic. Biol. Med. 2008, 45:1446-1456.